¼¼°èÀÇ ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀå
Medical Elastomers
»óǰÄÚµå : 1579779
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 81 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ¼¼°è ½ÃÀåÀº 2030³â±îÁö 152¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù

2023³â 95¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ¼¼°è ½ÃÀåÀº 2023-2030³â°£ ¿¬Æò±Õ 7.0% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 152¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¿­°¡¼Ò¼º ¿¤¶ó½ºÅä¸Ó´Â CAGR 7.2%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 94¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿­°æÈ­¼º ¿¤¶ó½ºÅä¸Ó ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 6.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 25¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 10.2%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀåÀº 2023³â 25¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 36¾ï ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³â°£ 10.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 3.7%¿Í 6.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¿¬Æò±Õ 4.3%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀο¡ ´ëÇÑ ¿ä¾à

ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó´Â ÀÇ·á±â±â Á¦Á¶¿¡ ¾î¶² Çõ¸íÀ» ÀÏÀ¸Å°°í Àִ°¡?

ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó´Â Ä«Å×ÅÍ, Æ©ºê, ¾Á, ¼ö¼ú ±â±¸ µî ´Ù¾çÇÑ ÀÇ·á±â±â Á¦Á¶¿¡ »ç¿ëµÇ´Â ´ÙÀç´Ù´ÉÇϰí À¯¿¬ÇÑ ¼ÒÀçÀÔ´Ï´Ù. ÀÌ ¿¤¶ó½ºÅä¸Ó´Â ³»±¸¼º, À¯¿¬¼º, »ýüÀûÇÕ¼ºÀ¸·Î Àß ¾Ë·ÁÁ® ÀÖÀ¸¸ç, Á¤È®¼º°ú ¾ÈÀü¼ºÀÌ °¡Àå Áß¿äÇÑ ÀÇ·á ºÐ¾ß¿¡ ÇʼöÀûÀÎ ¼ÒÀçÀÔ´Ï´Ù. ½Ç¸®ÄÜ, ¿­°¡¼Ò¼º ¿¤¶ó½ºÅä¸Ó(TPE), Æú¸®À̼ÒÇÁ·»Àº ÀÌ ºÐ¾ß¿¡¼­ ÀÚÁÖ »ç¿ëµÇ´Â Àç·áÀÔ´Ï´Ù. À̵éÀº ºñ¹ÝÀÀ¼ºÀ̱⠶§¹®¿¡ ÀÎü Á¶Á÷À̳ª ü¾×¿¡ Á÷Á¢ ´ê¾Æµµ ¾ÈÀüÇϸç, ´Ü±â ¹× Àå±â ÀÇ·á¿ëÀ¸·Î ÀûÇÕÇÕ´Ï´Ù. ÀÏȸ¿ë ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó´Â ÀÇ·á ºÐ¾ß¿¡¼­ Áß¿äÇÑ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀåÀ» Çü¼ºÇÏ´Â Çõ½ÅÀº ¹«¾ùÀΰ¡?

ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀåÀº Àç·á ±¸¼º°ú Á¦Á¶ °øÁ¤¿¡¼­ Å« Çõ½ÅÀ» °Þ°í ÀÖ½À´Ï´Ù. ¿¬±¸ °³¹ßÀÚµéÀº Àο­ ÀúÇ×, Çâ»óµÈ À¯¿¬¼º, ¿ì¼öÇÑ ³»È­Çмº µîÀÇ Æ¯¼ºÀ» °­È­ÇÑ °í¼º´É ¿¤¶ó½ºÅä¸Ó¸¦ °³¹ßÇϰí ÀÖ½À´Ï´Ù. ¿­°¡¼Ò¼º ¿¤¶ó½ºÅä¸Ó(TPE)´Â °í¹«ÀÇ Åº¼ºÀ» À¯ÁöÇϸ鼭 ÇÃ¶ó½ºÆ½Ã³·³ °¡°øÇÒ ¼ö Àֱ⠶§¹®¿¡ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, 3D ÇÁ¸°ÆÃ ±â¼úÀÇ Çõ½ÅÀ¸·Î ¿¤¶ó½ºÅä¸Ó ¼ÒÀçÀÇ ÀÇ·á±â±â¸¦ ´õ¿í º¹ÀâÇÏ°Ô ¼³°èÇÒ ¼ö ÀÖ°Ô µÇ¾î ¸ÂÃãÇü ÀÇÁ·, ¼ö¼ú µµ±¸, ¿þ¾î·¯ºí ÀÇ·á±â±â¸¦ Á¦ÀÛÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, Áö¼Ó °¡´ÉÇϰí ÀçȰ¿ëÀÌ °¡´ÉÇÑ ¿¤¶ó½ºÅä¸Ó´Â ÇコÄÉ¾î ¾÷°è°¡ ȯ°æ ¿µÇâÀ» ÁÙÀ̱â À§ÇØ ³ë·ÂÇϰí ÀÖ´Â °¡¿îµ¥ ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­´Â ÀÇ·á¿ë ¿¤¶ó½ºÅä¸ÓÀÇ ¼ºÀåÀ» ¾î¶»°Ô ±ÔÁ¤Çϴ°¡?

Àç·áÀÇ À¯Çü¿¡´Â ½Ç¸®ÄÜ ¿¤¶ó½ºÅä¸Ó, ¿­°¡¼Ò¼º ¿¤¶ó½ºÅä¸Ó(TPE), õ¿¬ °í¹« µîÀÌ ÀÖÀ¸¸ç, ½Ç¸®ÄÜ ¿¤¶ó½ºÅä¸Ó´Â ´Ù¾çÇÑ ÀÇ·á±â±â¿¡ ±¤¹üÀ§ÇÏ°Ô »ç¿ëµÇ±â ¶§¹®¿¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù. Ä«Å×ÅÍ, ¾Á, ÀÓÇöõÆ®, ¼ö¼ú ±â±¸ µî ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëµÇ¸ç, Ä«Å×ÅͰ¡ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. Àúħ½À ¼ö¼ú±â±¸¿Í ¿þ¾î·¯ºí ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. Áö¿ªº°·Î´Â ºÏ¹Ì¿Í À¯·´ÀÌ ¼±ÁøÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó¸¦ ¹ÙÅÁÀ¸·Î ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ´Â ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á±â±â »ê¾÷ È®Àå¿¡ ÈûÀÔ¾î ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

ÀÇ·á¿ë ¿¤¶ó½ºÅä¸Ó ½ÃÀåÀÇ ¼ºÀåÀº ÀÏȸ¿ë ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÃÖ¼Ò Ä§½À ¼ö¼ú Áõ°¡, ¿¤¶ó½ºÅä¸Ó Àç·á ±â¼úÀÇ ¹ßÀü µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Àå°©, ÁÖ»ç±â, Ä«Å×ÅÍ¿Í °°Àº ÀÏȸ¿ë ÀÇ·á±â±â´Â ƯÈ÷ Äڷγª19 ÆÒµ¥¹Í°ú °°Àº ¼¼°è º¸°Ç ¹®Á¦¿¡ ºñÃß¾î º¼ ¶§ °¨¿° °ü¸® ¹× ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ Çʿ伺À¸·Î ÀÎÇØ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àúħ½ÀÀû ¼ö¼ú·ÎÀÇ ÀüȯÀº ÀÎü ³»¿¡¼­ ¾ÈÀüÇÏ°Ô »ç¿ëÇÒ ¼ö ÀÖ´Â À¯¿¬ÇÑ »ýüÀûÇÕ¼º ¼ÒÀçÀÇ Çʿ伺À» Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ³»±¸¼º°ú ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½ÃŰ´Â ¿¤¶ó½ºÅä¸Ó ¹èÇÕÀÇ Çõ½ÅÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(18°³»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Medical Elastomers Market to Reach US$15.2 Billion by 2030

The global market for Medical Elastomers estimated at US$9.5 Billion in the year 2023, is expected to reach US$15.2 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Thermoplastic Elastomers, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$9.4 Billion by the end of the analysis period. Growth in the Thermoset Elastomers segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 10.2% CAGR

The Medical Elastomers market in the U.S. is estimated at US$2.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 10.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Medical Elastomers Market - Key Trends and Drivers Summarized

How Are Medical Elastomers Revolutionizing Medical Device Manufacturing?

Medical elastomers are versatile, flexible materials used in the production of various medical devices, including catheters, tubing, seals, and surgical instruments. These elastomers are known for their durability, flexibility, and biocompatibility, making them essential in medical applications where precision and safety are paramount. Silicone, thermoplastic elastomers (TPE), and polyisoprene are commonly used materials in this field. Their non-reactive properties ensure that they are safe for direct contact with human tissues and fluids, making them suitable for both short-term and long-term medical applications. With the increasing demand for disposable medical devices, medical elastomers are becoming a key component in healthcare.

What Innovations Are Shaping the Medical Elastomers Market?

The medical elastomers market is seeing significant innovations in material composition and manufacturing processes. Researchers are developing high-performance elastomers with enhanced properties such as greater tear resistance, improved flexibility, and superior chemical resistance. Thermoplastic elastomers (TPEs) are increasingly being used due to their ability to be processed like plastics while maintaining the elasticity of rubbers. Innovations in 3D printing technology are also allowing for more intricate designs in medical devices using elastomeric materials, enabling the creation of custom prosthetics, surgical instruments, and wearable medical devices. Additionally, sustainable and recyclable elastomers are gaining attention as the healthcare industry seeks to reduce its environmental impact.

How Do Market Segments Define the Growth of Medical Elastomers?

Material types include silicone elastomers, thermoplastic elastomers (TPE), and natural rubber, with silicone elastomers holding the largest share due to their extensive use in a variety of medical devices. Applications include catheters, seals, implants, and surgical instruments, with catheters being the dominant segment. The market is driven by the increasing demand for minimally invasive surgical tools and wearable medical devices. Regionally, North America and Europe dominate the market, thanks to their advanced healthcare infrastructure, while Asia-Pacific is experiencing rapid growth driven by the expansion of the medical device industry.

What Factors Are Driving the Growth in the Medical Elastomers Market?

The growth in the medical elastomers market is driven by several factors, including the increasing demand for disposable medical devices, the rise of minimally invasive surgeries, and advancements in elastomeric material technologies. Disposable medical devices such as gloves, syringes, and catheters are witnessing higher demand due to the need for infection control and patient safety, particularly in light of global health challenges like the COVID-19 pandemic. The shift towards minimally invasive surgical procedures is also driving the need for flexible, biocompatible materials that can be safely used inside the human body. Innovations in elastomer formulations, which enhance durability and patient comfort, are further propelling market growth.

Select Competitors (Total 18 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â